The District House is a benefit of District216. Come by for a portion or all of the evening, meet amazing members + guests, and interact with speakers on a variety of topics.
Topic: "Startups, Serontonin, & Serendipity: Discovery & Development of Novel Psychedelics for Mental Health"
Description: A presentation on how companies are working to create and develop new psychedelics and psychedelic-inspired drugs into FDA-approved treatments to address the growing mental health crisis. Learn about the process of drug discovery & development, the science of psychedelics, and some of the exciting new treatments that could be on the horizon.
When: Wednesday, July 30, 2025 from 5pm to 9pm (Speaker at 6:30pm)
Where: LoDo Studios, 216 E. Gutierrez Street, Santa Barbara, CA 93101(Please only park across the street on the Office Max side of the lot.)
Members are Free to attend The District House evenings, and are prioritized when we reach capacity.
Guests Welcome to purchase $25 tickets to The District House evenings.
Note: We will be filming the speaker for the District216 Change Your Lens Series. Refreshments provided.
SPEAKER BIO
Speaker: Dr. Adam Klein, Psychedelic Neuroscientist
Dr. Adam Klein is a neuropsychopharmacologist who specializes in understanding the neural and behavioral effects of psychedelic drugs. He has over a dozen publications on the neurobiology of psychedelics and other drugs and has presented his work at top conferences in both neuroscience and pharmacology. Dr. Klein currently works as a Senior Scientist at Gilgamesh Pharmaceuticals, a small biotech that is developing psychedelic, and psychedelic-inspired drugs to be the next generation of treatments for mental health. Additionally, “Dr. Adam” volunteers with RGX Medical to provide first-aid and a sanctuary space at music festivals. He also works closely with DanceSafe, a non-profit peer-to-peer harm reduction organization that provides drug education and drug checking services at music festivals.
